Concepedia

Marnix Lameijer

ML

4

Publications

645

Citations

4

H-Index

2018

Active since

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

New York University

Amsterdam UMC Location University of Amsterdam

Ludwig-Maximilians-Universität München

Harvard University

Marnix Lameijer is an author at Icahn School of Medicine at Mount Sinai specializing in nanomedicine, cell transplantation, and immunology.

Top concepts

MedicineImmunologyNanomedicineImmunotherapyCell TransplantationAutoimmunityCell BiologyCell TherapyInflammationTransplantation

Publications per year

2018–2021

4

Publications

4

Inhibiting Inflammation with Myeloid Cell-Specific Nanobiologics Promotes Organ Transplant Acceptance

Mounia S. Braza, Mandy M. T. van Leent, Marnix Lameijer et al. · Immunity · 2018 · 241 citations · Full text

Inflammation, Nanomedicine, Cell Therapy +9

Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis

Tom Seijkens, Claudia M. van Tiel, Pascal Kusters et al. · Journal of the American College of Cardiology · 2018 · 187 citations · Full text

Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates

Marnix Lameijer, Tina Binderup, Mandy M. T. van Leent et al. · Nature Biomedical Engineering · 2018 · 125 citations

Nanomedicine, Translational Medicine, Traf6-targeted Nanoimmunotherapy +10

Prosaposin mediates inflammation in atherosclerosis

Mandy M. T. van Leent, Thijs J. Beldman, Yohana C. Toner et al. · Science Translational Medicine · 2021 · 92 citations · Full text

Rows per page

1–4 of 4